Department of Clinical Sciences and Community Health, Università Degli Studi di Milano, Milan, Italy.
Department of Obstetrics and Gynecology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Arch Gynecol Obstet. 2024 Nov;310(5):2315-2332. doi: 10.1007/s00404-024-07666-0. Epub 2024 Sep 4.
The present systematic review aimed to assess the fecundity of women with congenital uterine anomalies (CUAs) undergoing assisted reproductive technology (ART).
The present systematic review of the literature was reported according to the PRISMA guidelines. We systematically searched PubMed, MEDLINE, Embase and Scopus, from database inception to 17th October 2023. Studies were deemed eligible only if they included women with CUAs clearly fitting into one of the categories of the ASRM Müllerian anomalies classification 2021.
Data relevant to the reproductive outcomes of women with CUAs who underwent ART were extracted from 55 studies. Regarding Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome, studies on gestational surrogacy reported a live birth rate (LBR) ranging from 37 to 54%. Uterus transplant, although still experimental, showed promising results. Most studies reported a negative impact of unicornuate uterus and partial or complete septate uterus on both the miscarriage rate (MR) and the live birth rate (LBR). The reproductive prognosis of women with unicornuate uterus was shown to be particularly poor in case of twin pregnancy. Uterus didelphys, bicornuate and arcuate uterus seem not to negatively impact the ART reproductive outcomes. Uterus didelphys was associated with an increased risk of preterm birth (PTB), cesarean section and low birth weight (LBW).
Women with CUAs should be informed regarding the impact (if any) of their congenital anomaly on both the chances of success of ART and on pregnancy-related complications. Elective single embryo transfer (eSET) should always be the first choice in patients with an increased baseline obstetric risk.
本系统评价旨在评估接受辅助生殖技术(ART)的先天性子宫畸形(CUA)女性的生育能力。
本系统评价文献的报告符合 PRISMA 指南。我们系统地检索了 PubMed、MEDLINE、Embase 和 Scopus,从数据库建立到 2023 年 10 月 17 日。只有明确符合 2021 年 ASRM Müllerian 异常分类标准之一类别的 CUA 女性的研究才被认为符合条件。
从 55 项研究中提取了与接受 ART 的 CUA 女性生殖结局相关的数据。关于 Mayer-Rokitansky-Kuster-Hauser(MRKH)综合征,妊娠代孕的研究报告活产率(LBR)范围为 37%至 54%。子宫移植虽然仍处于实验阶段,但结果有希望。大多数研究报告说,单角子宫和部分或完全纵隔子宫对流产率(MR)和活产率(LBR)都有负面影响。对于双胎妊娠,单角子宫女性的生殖预后尤其不佳。双子宫、双角子宫和弓形子宫似乎不会对 ART 生殖结局产生负面影响。双子宫与早产(PTB)、剖宫产和低出生体重(LBW)的风险增加有关。
应告知 CUA 女性其先天性异常对 ART 成功率和妊娠相关并发症的影响(如果有影响的话)。在基线产科风险增加的患者中,选择性单胚胎移植(eSET)应始终是首选。